¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pregnancy hormone"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pregnancy gingivitis
    ÀÓ½ÅÀÕ¸ö¿°, ÀÓ½ÅÄ¡Àº¿°
  • pregnancy induced retinopathy
    ÀÓ½ÅÀ¯¹ß¸Á¸·º´(Áõ)
  • pregnancy luteoma
    ÀÓ½ÅȲ(»ö)üÁ¾
  • pregnancy rate
    ÀÓ½ÅÀ²
  • pregnancy test
    ÀӽŰ˻ç
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • prolonged pregnancy
    Áö¼ÓÀÓ½Å
  • phantom pregnancy
    ȯ»óÀÓ½Å
  • stump pregnancy
    ÀÚ±ÃÀ߸°³¡ÀÓ½Å
  • unioval pregnancy
    À϶õ¼ºÀÓ½Å
  • antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
  • adrenal corticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸ó
  • adrenocortical hormone
    ºÎ½Å°ÑÁúÈ£¸£¸ó, ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenocorticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸ó
  • adrenomedullary hormone
    ºÎ½Å¼ÓÁúÈ£¸£¸ó, ºÎ½Å¼öÁúÈ£¸£¸ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pregnancy rate
    ÀÓ½ÅÀ²
  • pregnancy test
    ÀӽŰ˻ç
  • pregnancy induced retinopathy
    ÀÓ½ÅÀ¯¹ß¸Á¸·º´Áõ
  • prolonged pregnancy
    Áö¿¬ÀÓ½Å
  • stump pregnancy
    À߸°³¡ÀÓ½Å
  • term pregnancy
    ¸¸±âÀÓ½Å
  • tubal pregnancy
    ÀڱðüÀÓ½Å
  • twin pregnancy
    ½ÖµÕÀÌÀÓ½Å
  • unioval pregnancy
    À϶õ¼ºÀÓ½Å
  • adrenal corticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó
  • adrenocortical hormone
    ºÎ½Å°ÑÁúÈ£¸£¸ó
  • adrenocorticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó
  • adrenomedullary hormone
    ºÎ½Å¼ÓÁúÈ£¸£¸ó
  • androgenic hormone
    ³²¼ºÈ£¸£¸ó
  • antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pregnancy,spider telangiectasia
    °Å¹Ì¸ð¾çÇ÷°üÈ®ÀåÁõ(¸ð¼¼Ç÷°üÈ®ÀåÁõ)(¡­Ù¼åÆúìηüªíåñø(Ù¾á¬úìηüªíåñø))
  • primary ovarian pregnancy
    ÀÏÂ÷³­¼ÒÀÓ½Å(¡­Õ°áµìôãã).
  • primary pregnancy
    ÀÏÂ÷ÀÓ½Å
  • prolonged pregnancy
    Áö¿¬ÀÓ½Å(òÀæÅìôãã).
  • recurrent jaundice of pregnancy
    ¹Ýº¹¼º Àӽżº(ÚãÜÖàõìôããàõ)Ȳ´Þ.
  • recurrent jaundice of pregnancy
    ¹Ýº¹¼º ÀӽżºÈ²´Þ(ÚãÜÖàõìôããàõüÜÓ¸)
  • ACTH=£¾adrenocorticotropic hormone
    ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸ó
  • ADH =£¾antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
  • CRH (corticotropin releasing hormone)
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñÈ£¸£¸ó
  • Corticotropin releasing hormone
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇɺкñÈ£¸£¸ó
  • FSH= follicle stimulating hormone
    ³­Æ÷ÀÚ±Ø(Õ°øàí©Ð½)È£¸£¸ó.
  • FSH= follicle stimulating hormone
    ³­Æ÷ÀÚ±ØÈ£¸£¸ó.
  • Fetal thyroid-stimulating hormone
    žư©»ó¼±ÀÚ±Ø(÷Ãä®Ë£ßÒàÍí©Ð½)È£¸£¸ó
  • Follicle-stimulation hormone
    ³­Æ÷ÀÚ±Ø(Õ°øàí©Ð½)È£¸£¸ó
  • GH= growth hormone
    ¼ºÀå È£¸£¸ó.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hydatid pregnancy
    ±âÅÂÀÓ½Å(ѱ÷Ãìôãã).
  • hypertrichosis gravitatis =Halban s pregnancy sign ³ª
    ÀÓºÎ(ìôÜþ)´Ù¸ð(Áõ).
  • hysteric pregnancy
    È÷½ºÅ׸®¼º ÀÓ½Å(¡­ìôãã),»ó»óÀÓ½Å(ßÌßÀìôãã)
  • hysteric pregnancy
    È÷½ºÅ׸®¼º ÀÓ½Å(¡­ìôãã) »ó»óÀÓ½Å(ßÌßÀìôãã) .
  • imaginary pregnancy
    »ó»óÀÓ½Å
  • imaginary pregnancy
    »ó»óÀÓ½Å.
  • interstitial pregnancy
    (³­°ü)°£ÁúÀÓ½Å.
  • interstitial pregnancy
    Àڱú®ÀڱðüÀÓ½Å
  • intrahepatic cholestasis of pregnancy
    Àӽżº °£³»´ãÁó¿ïü(ìôããàõÊÜÒ®ÓÅ ê¦ô÷).
  • intraligamentary pregnancy
    Àڱñ¤°£¸·ÀÓ½Å(í­ÏàÎÆÊàØ¯ìôãã).
  • intramural pregnancy
    º®³»ÀÓ½Å(ÛúÒ®ìôãã).
  • isthmial pregnancy
    (³­°ü)ÇùºÎÀÓ½Å(հηúòÝ»ìôãã).
  • membranous pregnancy
    ¸·¾çÀÓ½Å(دåÆìôãã).
  • membranous pregnancy
    ¸·ÆÄ¿­¼ºÀÓ½Å.
  • mesenteric pregnancy
    Àå°£¸·ÀÓ½Å(¡­ìôãã).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hormone
    È£¸£¸ó
  • hypothalamic hormone
    ½Ã»óÇϺÎ(ãÊßÉù»Ý») È£¸£¸ó
  • interstitial cell hormone
    °£Áú¼¼Æ÷(Êàòõá¬øà) È£¸£¸ó
  • interstitial cell-stimulating hormone
    °£Áú¼¼Æ÷(Êàòõá¬øà)ÀÚ±Ø(í©Ð½) È£¸£¸ó
  • juvenile hormone
    ¼Ò¾Æ(á³ä®) È£¸£¸ó
  • lactogenic hormone
    ÃÖÀ¯(õÊêá)È£¸£¸ó
  • lightening hormone
    ¼¶±¤(àìÎÃ) È£¸£¸ó
  • lipotrophic hormone
    ÁöÁúÀÚ±Ø(ò·òõí©Ð½)È£¸£¸ó
  • lipotropic hormone
    ÁöÁúÀÚ±Ø(ò·òõí©Ð½) È£¸£¸ó
  • local hormone
    ±¹¼Ò(ÏÑá¶)È£¸£¸ó
  • luteotrophic hormone
    ȲüÀÚ±Ø(üÜô÷í©Ð½)È£¸£¸ó
  • luteotropic hormone
    ȲüÀÚ±Ø(üÜô÷í©Ð½)È£¸£¸ó
  • melanocyte-stimulating hormone
    ¸á¶ó´Ñ¼¼Æ÷ÀÚ±Ø(á¬øàí©Ð½) È£¸£¸ó
  • molting hormone
    Å»ÇÇ(÷­ù«)È£¸£¸ó
  • natriuretic hormone
    ¼Òµð¿ò¹è¼³Áõ°¡(ÛÉàÜñòÊ¥) È£¸£¸ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FSH-RH follicle-stimulating hormone-releasing hormone
GDH glucose dehydrogenase; glutamate dehydrogenase; glycerophosphate dehydrogenase; glycol dehydrogenase...
GH-RH growth hormone-releasing hormone
GHRHR growth hormone-releasing hormone receptor
GH-RIH growth hormone-release inhibiting hormone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PTH/PTHrP Parathyroid hormone/parathyroid-hormone-related peptide
GnRH gonadotropin hormone releasing hormone
PAG 2-pregnancy-associated glycoprotein
AFLP Acute fatty liver of pregnancy
ALSPAC Avon Longitudinal Study of Pregnancy and Childhood
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • luteinizing hormone
    Ȳüȭ È£¸£¸ó, Ȳü Çü¼º È£¸£¸ó
  • luteotropic hormone
    Ȳü ÀÚ±Ø È£¸£¸ó
    Ȳü Çü¼ºÀ» ÀÚ±ØÇÏ´Â Çϼöü Àü¿± È£¸£¸ó.
  • lutinizing hormone
    Ȳüȭ È£¸£¸ó
  • male hormone
    ³²¼º È£¸£¸ó
    ³²¼º °íȯÀÇ °£ ¼¼Æ÷¿¡¼­ ºÐºñµÇ´Â ¾Èµå·Î°Õ. µ¿¹°ÀÇ ¿õ¼º È£¸£¸ó¿¡ ÇØ´çÇÏ´Â ¼º È£¸£¸óÀ¸·Î¼­, ºÎ¼º±â
  • male sex hormone
    ³²¼º È£¸£¸ó
  • medulloid hormone
    ¼öÁú¾ç È£¸£¸ó
  • melanocyte stimulating hormone
    Èæ»ö ¼¼Æ÷ ÀÚ±Ø È£¸£¸ó
  • melanocyte-stimulating hormone
    Èæ»ö ¼¼Æ÷ ÀÚ±Ø È£¸£¸ó, ¸á¶ó´Ñ ¼¼Æ÷ ÀÚ±Ø È£¸£¸ó
    ³úÇϼöü Áß¿±¿¡¼­ ºÐºñµÇ¸é¼­ ü»ö º¯È­¿¡ °ü°èÇϴ ȣ¸£¸ó. ¸á¶ó³ëÆ®·ÎÇÉ
  • melanophore hormone
    ¸á¶ó³ëÆ÷¸£ È£¸£¸ó
  • melanophorotropic hormone
    ¸á¶ó³ëÆ÷¸£ ģȭ¼º È£¸£¸ó
  • molting hormone
    Å»ÇÇ È£¸£¸ó
  • N-hormone
    N-È£¸£¸ó
    ºÎ½Å ÇÇÁú ³»ºÐºñ È£¸£¸óÀÇ Çϳª.
  • natriuretic hormone
    ³ªÆ®·ý ¹è¼³ Áõ°¡ È£¸£¸ó, ³ªÆ®·ý ¹è¼³ ÃËÁø È£¸£¸ó
  • pancreatic hormone
    ÃéÀå È£¸£¸ó
  • parathyroid hormone
    ºÎ°©»ó¼± È£¸£¸ó
    1. ºÎ°©»ó¼± È£¸£¸óÀÇ ÁÖ¿ä »ý¸®Àû ±â´ÉÀº ´ÙÀ½°ú °°´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
pregnancy, abdominal Ectopic pregnancy with development of the foetus in the abdominal cavity.
(12 Dec 1998)
pregnancy, alcohol in The consumption of alcohol during pregnancy carries the danger of damaging the foetus and causing foetal alcohol syndrome or foetal alcohol effects.
(12 Dec 1998)
pregnancy-associated alpha-plasma protein An alpha 2-macroglobulin, molecular weight approximately 750,000 now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation.
(12 Dec 1998)
pregnancy-associated beta-plasma protein A beta-globulin now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during pregnancy until the end of gestation.
(12 Dec 1998)
pregnancy-associated esterase <enzyme> In baboons, amount of activity correlates with stage of pregnancy; hydrolyzes alpha-naphthyl butyrate in preference to alpha-naphthyl acetate
Registry number: EC 3.1.1.-
Synonym: pregnancy esterase
(26 Jun 1999)
pregnancy cells Hypophysial chromophobe cell's that increase in number and accumulate eosinophil granules during pregnancy.
(05 Mar 2000)
pregnancy complications The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus.
(12 Dec 1998)
pregnancy complications, cardiovascular The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus.
(12 Dec 1998)
pregnancy complications, haematologic The co-occurrence of pregnancy and a blood disease. The haematologic disorder may be of the cells or coagulation elements of the blood but does not refer to deficiencies or excesses of various substances in the blood, such as hypercalcaemia or hypocalcaemia. It may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or foetus.
(12 Dec 1998)
pregnancy complications, infectious Infections occurring during the course of pregnancy, or pregnancy during the course of an infectious disease.
(12 Dec 1998)
pregnancy complications, neoplastic Neoplasms occurring during the course of pregnancy, or pregnancy during the course of a neoplastic disease.
(12 Dec 1998)
pregnancy complications, parasitic Parasitic diseases occurring during the course of pregnancy, or pregnancy during the course of a parasitic disease. Some of the more commonly co-occurring infections are amebiasis, malaria and toxoplasmosis.
(12 Dec 1998)
pregnancy danger from fifth disease Caused by a virus known as parvovirus b 19. Symptoms include low-grade fever, fatigue, a slapped cheeks rash, and a rash over the whole body. The illness is not serious in children. Pregnant women (who have not previously had the illness) should avoid contact with patients who have fifth disease. The virus can infect the foetus prior to birth. And, while no birth defects have been reported as a result of fifth disease, it can cause the death of the unborn foetus. The risk of foetal death is 5-10% if the mother becomes infected.
(12 Dec 1998)
pregnancy danger from urinary tract infection A pregnant woman who develops a uti should be treated promptly to avoid premature delivery of her baby and other risks such as high blood pressure. Some antibiotics are not safe to take during pregnancy. In selecting the best treatment, doctors consider various factors such as the drug's effectiveness, the stage of pregnancy, the mother's health, and potential effects on the foetus.
(12 Dec 1998)
pregnancy diabetes See: subclinical diabetes.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á